Pitch deck presentation Maïa Africa 2025 2030 is a report document. in deploy capital. Investment deck for Maia outlining the company, problem/opportunity, product, market, business model, traction, team, and current raise. Core fundraising document used to evaluate the opportunity quickly and support internal discussion, follow-up, and investor communication.. Why it matters: This is a primary diligence and fundraising artifact. It gives the team a shared baseline on what Maia is building, what capital is being raised for, and how the opportunity should be assessed, discussed, and refer…
Description
Investment deck for Maia outlining the company, problem/opportunity, product, market, business model, traction, team, and current raise. Core fundraising document used to evaluate the opportunity quickly and support internal discussion, follow-up, and investor communication.
Why it matters
This is a primary diligence and fundraising artifact. It gives the team a shared baseline on what Maia is building, what capital is being raised for, and how the opportunity should be assessed, discussed, and referenced in future investment and relationship decisions.
Pitch, Mai, Africa, Protecting African, Confidential, Summary, Problem
Insight
Business, Solution
Evidence
Impact
Notes
—
Edit metadata
Usable content
Uploaded content is treated as untrusted evidence. It is viewable and referenceable here, but it is not automatically trusted, executable, or promoted into canon/state/memory/action.
Normalized text is stored in the registry/backbone, not local prototype storage.
Protecting African families from malaria
using their daily habits
Pitch deck - Confidential - 01/07/2025
Summary
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Problem
Insight
Business model
Solution
Evidence
Impact target
1 child dies from malaria every 2 minutes in Africa
Most children are coated with an ointment in the evening, when they are very vulnerable
MAÏA, 1
st
moisturizing ointment offering 8 hours of protection against Anopheles
R&DOutsourced productionDistribution: Retail, Community agents, NGOs
2 scientific publications1 million jars sold so far
> 1,500 PoS
2 millon malaria cases averted - 6,700 lives saved by 2030
Sales target
Reach 27 million jars sold in 13 countries most affected by malaria in Africa.
Problem
597,000 deaths
263 million cases
95%
children under 5 years old
Source: World malaria report 2024. Geneva: World Health Organization; 2024
Malaria in Africa
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Mosquitoes become resistant
Insecticide-treated bed nets,
are less effective against malaria,
as Anopheles mosquitoes:
•die less at their contact
•bite more outdoors and in the evening
when people are unprotected.
SummaryTeamSolutionModelImpactProblemRoadmapFinance
"Tools are needed to protect people
when they are outside their homes"
WHO Technical Strategy for Malaria 2016-2030
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Team
Our 7 business angels
We are fortunate to have 7 non-executive partners who support
the project with their advice and experience:
•Christian AREND, Ex-CEO Goupe Urgo
•Ousmane Abdoulaye DIOP, Financial expert
•Anne DOUSSET, Ex-HRD Danone
•Michel HUSSHERR, BA, ex-dir. incubator
•Dr Jérôme NTARIMA, Head of ICRC
•Bruno RENIER, Ex-entrepreneur
•Lisa TIETIEMBOU, Director of La Fabrique incubator
Gérard
NIYONDIKO
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Franck
LANGEVIN
Business
angels
Capital allocation
Executive team
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Frank Langevin
Co-founder / CEO
Graduated from Stanford, DCU and Neoma
12 years of experience in innovation
Gérard Niyondiko
Co-founder / GM
2iE graduate engineer / chemist
10 years of experience
Assitan Monekata
COO
Ex-GM at Univeler, Wave, B.A.T.
20 years in marketing & distribution
Solution
Solution
Most African children are
coated with ointment
In Burkina Faso, 80% of children
receive an ointment daily to
moisturize their skin.
To change
when mosquitoes start biting
The ointment is generally used in
the evening at 5 p.m., when the
Anopheles begin to bite.
where they are most
vulnerable
The ointment is particularly used
in rural and semi-urban areas.
Source: Roger Zerbo Maria Theresa Somé Arcens (2018), Personal hygiene and protection against mosquitoes in Burkina Faso, Institute of Social Sciences (INSS)
Starting from family habits
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Mobilize experts
Study on
hygiene habits
Efficiency tests of
mosquito repellents
National
Research Center
and Training on
Malaria
Efficiency tests of
mosquito repellents
Toxicity tests
Research
Institute
in Science
Health
Toxicity tests
Sensory tests
Impact assessment
Physico-chemical tests
National
Laboratory of
Public health
SummaryTeamSolutionModelImpactProblemRoadmapFinance
MAIA
®
is the first 2-in-1 ointment
designed to offer every family
a double protection.
Deep hydration
with nourishing local shea butter
> 8 hours of mosquito protection
witnessed in Burkina Faso and Tanzania
Affordable
From 900F per 100ml jar
MAÏA
®
, our first product
SummaryTeamSolutionModelImpactProblemRoadmapFinance
MAIA
®
is the first 2-in-1 ointment
designed to offer every family
a double protection.
Scientifically proven effectiveness
SummaryTeamSolutionModelImpactProblemRoadmapFinance
“MAÏA® repellent ointment offers complete protection
for 9 hours against An. Gambiae and An. Arabiensis.
MAÏA® repellent ointment can be recommended as a
preventive tool against outdoor biting mosquitoes in
tropical areas where the majority of people spend a lot
of time outdoors before going to bed. »
Malaria Journal
January 2021
Scientifically proven effectiveness
SummaryTeamSolutionModelImpactProblemRoadmapFinance
A growing success
96%
of clients
recommend it
to third parties
Source: Impact study
July 2020
86%
of users
consider it very effective
Source: ACTED PDM Report
October 2021
98%
of users
use it > 4 times
per week
Source: PDM ACF Report
December 2021
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Delighted customers
SummaryTeamSolutionModelImpactProblemRoadmapFinance
MAÏA® is the only African mosquito-repellent
product to have obtained a marketing approval
from the “Comité Sahélien des Pesticides”,
valid in 11 countries:
Only Africa made product authorized
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Burkina Faso
Cabo Verde
Côte d’Ivoire
Gambia
Guinea Bissau
Liberia
Coming in 2025:
Benin
Mali
Mauritania
Niger
Senegal
Tchad
Uganda
National phase filing in:
•35 West and East African countries
•27 countries of the European Union
•United States
A patent pending in 63 countries
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Business model
A scalable model on the continent
Design and test
products with
laboratories
Source ingredients
and outsource the
production
Lead the marketing
campaigns
Distribute via
retailers, community
agents & NGOs
SummaryTeamSolutionModelImpactProblemRoadmapFinance
SummaryTeamSolutionModelImpactProblemRoadmapFinance
High production
capacity in Africa
•Production subcontracted to leading
cosmetics manufacturers in West Africa
(Dream Cosmetics, Côte d’Ivoire) and
East Africa (Wispro, Uganda) in Q1 2025.
•Most ingredients locally sourced
(shea butter, cotton seed oil, beeswax)
Urban &
semi-urban families
Rural families
Highly vulnerable families
Served by NGOs
Served by Community Agents
Served by Retailers
(shops, pharmacies, etc.)
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Distribution optimized for high impact
Retailers
to reach urban and semi-urban families
MAÏA distributed in >1,500 outlets
(shops, pharmacies, gas stations, kiosks, etc.)
6 partnered wholesalers
to extend distribution to local retailers
Digital co-piloting
Use of mobile technology for real-time
evaluation of the location of points of sale, sales,
prices and stocks.
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Retailers
>1,500 points of sale in West Africa
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Community agents
to reach rural families
Malaria incidence 4 times more important
in rural than in urban families.
We work with community agents to:
•raise awareness about malaria prevention
•invite families to test et buy MAÏA at
promotional prices directly to rural families.
This innovative distribution model is supported in
Burkina Faso by the Monaco government and in
Uganda by Grand Challenges Canada.
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Community agents
selling in 6 regions in Burkina Faso
NGOs
to reach highly vulnerable families
Advocacy for the integration of MAÏA
MAÏA is now recommended in Burkina Faso in:
•hygiene kits by the WASH cluster (led by UNICEF)
•Dignity Kits by GBV Cluster (led by UNICEF)
•Shelter Kits by Shelter Cluster (led by UNHCR)
Distribution to people vulnerable to malaria
More than 42,000 internally displaced people received
MAÏA in 2021. We work with:
SummaryTeamSolutionModelImpactProblemRoadmapFinance
1M
distributed jars
since 2020
>1,500
points of sale
Key distribution figures
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Impact
Maximize impact
•We distribute MAÏA to as many people as possible
in the areas of Africa most affected by malaria. (SDG target 3.3)
•We adopt a rigorous scientific approach
in compliance with WHO standards.
•In 2020, we received the “B-Corp” certification attesting to our
strong social and environmental standards.
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Scientifically measure the impact
EFFICACY
X
=
Efficacy studies
mosquito repellent
Made in Burkina Faso
and Tanzania
Total budget :
40.000€
Study on the willingness to
pay and use MAÏA
Made
in Burkina Faso
Total budget :
1.000.000€
Study on the
epidemiological impact
Planned in Ivory Coast and
Tanzania
Total budget :
1.200.000€
USE
USE
IMPACT
IMPACT
SummaryTeamSolutionModelImpactProblemRoadmapFinance
A recognized approach
SummaryTeamSolutionModelImpactProblemRoadmapFinance
2022
Top 50
2024 track record
398k€
Sales
114k€
Net profit
2024 financial results
SummaryTeamSolutionModelImpactProblemRoadmapFinance
187k€
Grants
Roadmap 2025-2030
Our goals by 2030
Distribute 27 million MAÏA jars
in 13 countries
most affected by malaria
3 locations of production
West Africa (Abidjan)
East Africa (Kampala)
Central Africa (Kinshasa)
SummaryTeamSolutionModelImpactProblemRoadmapFinance
6,700 lives
saved
2,2 million malaria cases
averted
estimated with epidemiological model
from Dr Anthony Kiszewski, Bentley University
Our impact goals by 2030
SummaryTeamSolutionModelImpactProblemRoadmapFinance
Deployment in 4 phases
SummaryTeamSolutionModelImpactProblemRoadmapFinance
PreparationLaunchScaleMaintain
●Market
research
●Regulatory
compliance
●Advocacy
to NMCP
●Key distribution
partnerships
●Operat. setup
in capital city
●Distribution
activation
●Local marketing
campaigns
●Community
Engagement
●Marketing
Intensification
●Wholesaler
recruitment
●Door-to-door
promotion
●NGO
partnerships
●Distribution
extension
●Performance
optimization
●Integration in
national policy
13 targeted countries
SummaryTeamSolutionModelImpactProblemRoadmapFinance
202520262027202820292030
Burkina FasoScaleScaleMaintainMaintainMaintainMaintain
MaliLaunchScaleScaleMaintainMaintainMaintain
BeninPrepareLaunchScaleScaleMaintainMaintain
Côte d'IvoirePrepareLaunchScaleScaleMaintainMaintain
NigerPrepareLaunchScaleScaleMaintainMaintain
OugandaPrepareLaunchScaleScaleMaintainMaintain
Sierra Leone
PrepareLaunchScaleScaleMaintain
Guinea
PrepareLaunchScaleScaleMaintain
Liberia
PrepareLaunchScaleScaleMaintain
Togo
PrepareLaunchScaleScaleMaintain
Nigeria
PrepareLaunchScaleScaleMaintain
RDC
PrepareLaunchScaleScaleMaintain
Tanzania
PrepareLaunchScaleScaleMaintain
Fundraising of $2M
Capital type needed
SummaryTeamSolutionModelImpactProblemRoadmapFinance
We’ve designed a funding strategy that matches each type
of capital with the most relevant expenditures:
$1M in Grants - Boosting market entry
●Promotional product launch ($800,000)
●Community engagement ($110,000)
●Regulatory approvals ($90,000)
$500K in Debt – Securing operational execution
●Working capital ($300,000)
●Supply chain & logistics ($140,000)
●Team setup & country operations ($60,000)
$500K in Equity – Driving long-term value
●Mass media & POS branding ($250,000)
●Retail distribution expansion ($160,000)
●New product development ($90,000)
Thank you
